ADAM29 (ADAM metallopeptidase domain 29)

2012-12-01  

Identity

HGNC
LOCATION
4q34.1
LOCUSID
ALIAS
CT73,svph1
FUSION GENES

Other Information

Locus ID:

NCBI: 11086
MIM: 604778
HGNC: 207
Ensembl: ENSG00000168594

Variants:

dbSNP: 11086
ClinVar: 11086
TCGA: ENSG00000168594
COSMIC: ADAM29

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000168594ENST00000359240Q9UKF5
ENSG00000168594ENST00000359240A0A140VJD8
ENSG00000168594ENST00000404450Q9UKF5
ENSG00000168594ENST00000404450A0A140VJD8
ENSG00000168594ENST00000445694Q9UKF5
ENSG00000168594ENST00000445694A0A140VJD8
ENSG00000168594ENST00000502305D6RBU0
ENSG00000168594ENST00000502940D6RHU0
ENSG00000168594ENST00000505141D6RIU9
ENSG00000168594ENST00000514159Q9UKF5
ENSG00000168594ENST00000514159A0A140VJD8
ENSG00000168594ENST00000615367Q9UKF5
ENSG00000168594ENST00000615367A0A140VJD8
ENSG00000168594ENST00000618444Q9UKF5
ENSG00000168594ENST00000618444A0A140VJD8

Expression (GTEx)

0
5
10
15
20
25
30
35
40

Pathways

PathwaySourceExternal ID
Metabolic pathwaysKEGGhsa01100

References

Pubmed IDYearTitleCitations
158025352005The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia.31
216183422011Analysis of the disintegrin-metalloproteinases family reveals ADAM29 and ADAM7 are often mutated in melanoma.17
193404282009IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide.9
247326602014Gene expression profiles in peripheral blood mononuclear cells of Asian obstructive sleep apnea patients.1
269770222016ADAM29 Expression in Human Breast Cancer and its Effects on Breast Cancer Cells In Vitro.1

Citation

Dessen P

ADAM29 (ADAM metallopeptidase domain 29)

Atlas Genet Cytogenet Oncol Haematol. 2012-12-01

Online version: http://atlasgeneticsoncology.org/gene/53069/adam29